229 related articles for article (PubMed ID: 34342126)
21. Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery.
Huang L; Yang J; Wang T; Gao J; Xu D
J Nanobiotechnology; 2022 Jan; 20(1):49. PubMed ID: 35073914
[TBL] [Abstract][Full Text] [Related]
22. Stimuli-responsive prodrug-based cancer nanomedicine.
Xie A; Hanif S; Ouyang J; Tang Z; Kong N; Kim NY; Qi B; Patel D; Shi B; Tao W
EBioMedicine; 2020 Jun; 56():102821. PubMed ID: 32505922
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.
Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z
ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426
[TBL] [Abstract][Full Text] [Related]
24. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
[TBL] [Abstract][Full Text] [Related]
25. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
26. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
28. Supramolecular nanomedicines through rational design of self-assembling prodrugs.
Wang H; Monroe M; Leslie F; Flexner C; Cui H
Trends Pharmacol Sci; 2022 Jun; 43(6):510-521. PubMed ID: 35459589
[TBL] [Abstract][Full Text] [Related]
29. Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy.
Chen X; Xie B; Huang L; Wan J; Wang Y; Shi X; Qiao Y; Song H; Wang H
Theranostics; 2021; 11(12):5713-5727. PubMed ID: 33897877
[TBL] [Abstract][Full Text] [Related]
30. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
Wang Z; Chen J; Little N; Lu J
Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
[TBL] [Abstract][Full Text] [Related]
31. Transforming a highly toxic agent DM1 into injectable safe nanomedicines
Huang J; Song S; Wang M; Wang H
Nanoscale; 2023 Jun; 15(23):10110-10124. PubMed ID: 37255385
[TBL] [Abstract][Full Text] [Related]
32. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
33. Dimerization-induced self-assembly of a redox-responsive prodrug into nanoparticles for improved therapeutic index.
Zhou L; Xie H; Chen X; Wan J; Xu S; Han Y; Chen D; Qiao Y; Zhou L; Zheng S; Wang H
Acta Biomater; 2020 Sep; 113():464-477. PubMed ID: 32652227
[TBL] [Abstract][Full Text] [Related]
34. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
[TBL] [Abstract][Full Text] [Related]
35. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.
Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z
Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822
[TBL] [Abstract][Full Text] [Related]
36. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
[TBL] [Abstract][Full Text] [Related]
37. Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety.
Xu H; Zuo S; Wang D; Zhang Y; Li W; Li L; Liu T; Yu Y; Lv Q; He Z; Sun J; Sun B
J Control Release; 2023 Aug; 360():784-795. PubMed ID: 37451544
[TBL] [Abstract][Full Text] [Related]
38. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy.
Shim MK; Park J; Yoon HY; Lee S; Um W; Kim JH; Kang SW; Seo JW; Hyun SW; Park JH; Byun Y; Kwon IC; Kim K
J Control Release; 2019 Jan; 294():376-389. PubMed ID: 30550940
[TBL] [Abstract][Full Text] [Related]
39. A unique highly hydrophobic anticancer prodrug self-assembled nanomedicine for cancer therapy.
Ren G; Jiang M; Xue P; Wang J; Wang Y; Chen B; He Z
Nanomedicine; 2016 Nov; 12(8):2273-2282. PubMed ID: 27389147
[TBL] [Abstract][Full Text] [Related]
40. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
